1. Home
  2. OPTT vs ALZN Comparison

OPTT vs ALZN Comparison

Compare OPTT & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ocean Power Technologies Inc.

OPTT

Ocean Power Technologies Inc.

N/A

Current Price

$0.43

Market Cap

5.9M

Sector

Utilities

ML Signal

N/A

Logo Alzamend Neuro Inc.

ALZN

Alzamend Neuro Inc.

N/A

Current Price

$1.43

Market Cap

5.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OPTT
ALZN
Founded
1984
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Medicinal Chemicals and Botanical Products
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9M
5.5M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
OPTT
ALZN
Price
$0.43
$1.43
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $45.00
N/A
AVG Volume (30 Days)
★ 606.2K
28.6K
Earning Date
12-14-2026
12-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 76.77
EPS
N/A
★ N/A
Revenue
★ $3,737,000.00
N/A
Revenue This Year
$286.98
N/A
Revenue Next Year
$131.02
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.10
$0.84
52 Week High
$3.23
$2.56

Technical Indicators

Market Signals
Indicator
OPTT
ALZN
Relative Strength Index (RSI) 38.55 53.40
Support Level $0.40 $1.41
Resistance Level $0.52 $2.20
Average True Range (ATR) 0.08 0.14
MACD -0.01 0.05
Stochastic Oscillator 20.65 58.04

Price Performance

Historical Comparison
OPTT
ALZN

About OPTT Ocean Power Technologies Inc.

Ocean Power Technologies Inc is specializing in intelligent maritime solutions. These solutions include a variety of as a service systems, including Data as a Service (DaaS), Robotics as a Service (RaaS), and Power as a Service (PaaS). It design, manufacture, deploy, and operate these systems for defense, security, subsea infrastructure, offshore oil and gas, offshore energy, marine research, and communication markets. The company operates as one operating segment. Majority of revenue comes from Europe followed by North & South America; and followed by Asia and Australia.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's disease. The Company has two therapeutic drug candidates, AL001 and ALZN002. Its pipeline consists of AL001, a patented ionic cocrystal technology delivering lithium through a therapeutic combination of lithium, proline and salicylate; and ALZN002, a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's disease.

Share on Social Networks: